With more than €350m, our Healthcare team Turenne Santé invests across the entire value creation chain for healthcare companies through various investment approaches:

Growth & buyout capital

Capital Santé supports profitable healthcare companies with their organic growth and acquisitions, as well as their buyout projects. 

Healthcare venture capital

Created in July 2014, Relyens Innovation Santé is an SCR (French venture capital company or “Société de Capital Risque”), a subsidiary of Relyens, advised by the Turenne Group and dedicated to investment in innovative companies, particularly in biotech and medical devices.

Béatrice Denys foundation for therapeutic innovation

Turenne Santé also heads up the Béatrice Denys foundation for therapeutic innovation, which recognises the most successful projects within academic medical research in France, under the aegis of the Fondation pour la Recherche Médicale.